Showing 7961-7970 of 21408 results for "".
- You May Be Breathing in More Tiny Nanoparticles from Your Gas Stove Than from Car Exhausthttps://reachmd.com/news/you-may-be-breathing-in-more-tiny-nanoparticles-from-your-gas-stove-than-from-car-exhaust/2457339/In this Purdue-designed "tiny house" lab, Purdue researchers used instrumentation from GRIMM AEROSOL TECHNIK, a member of the DURAG GROUP, to more accurately study nanocluster aerosol partic
- White House Commitments to End Hunger, Reduce Diet-Related Diseasehttps://reachmd.com/news/white-house-commitments-to-end-hunger-reduce-diet-related-disease/2457343/Two Tufts-related initiatives have been included in the White House’s new round of public and private sector commitments, announced today by the Biden-Harris administration, to end hunger, improve nutrition, and reduce diet-related disease in the United States by 2030. Th
- CD19 CAR T-Cell Transfer Therapy Shows Promise for Systemic Lupus Erythematosushttps://reachmd.com/news/cd19-car-t-cell-transfer-therapy-shows-promise-for-systemic-lupus-erythematosus/2457333/Results from a recent analysis in the New England Journal of Medicine suggested a potentially effective approach for treating autoimmune diseases like systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis. The case series
- New Disease Testing Component Facilitates Lower-Cost Diagnosticshttps://reachmd.com/news/new-disease-testing-component-facilitates-lower-cost-diagnostics/2457340/A new tool could reduce costs for diagnosing infectious diseases. Biomedical researchers from The University of Texas at Austin have developed a new, less expensive way to detect nuclease digestion – one of the critical steps in many nucleic acid sensing appl
- Teens Benefit from "Forest Bathing" – Even in Citieshttps://reachmd.com/news/teens-benefit-from-forest-bathing-even-in-cities/2457337/Youth mental health in urban environments is significantly better when more nature is incorporated into city design. A new study from University of Waterloo researchers suggests that forest bathing, the simple method of being calm and quiet amongst the trees, observing nature ar
- What Math Tells Us About Social Dilemmashttps://reachmd.com/news/what-math-tells-us-about-social-dilemmas/2457328/Mathematics plays a crucial role in understanding and analyzing various aspects of human behavior, including social dilemmas. Social dilemmas are situations where individuals must choose between their own self-interest and the collective good, often leading to complex decisio
- Live Music Emotionally Moves Us More Than Streamed Music, Show Researchershttps://reachmd.com/news/live-music-emotionally-moves-us-more-than-streamed-music-show-researchers/2457319/When it comes to experiencing music, there is a distinct difference between attending a live concert and listening to music through streaming platforms. Recent research suggests that live music has a more profound emotional impact on us compared to streamed music. The Power of Live Music
- UC Research Examines Chronic Sinusitishttps://reachmd.com/news/uc-research-examines-chronic-sinusitis/2457329/The researchers concluded that the results have important implications for education of patients about CRS and increasing CRS health literacy, particularly in regions where environmental allergies may be both highly prevalent and culturally entrenched, such as the Cincinnati area.
- Protein Levels in Plasma Highly Predictive of Future Dementia Risk According to UK Biobank Studyhttps://reachmd.com/news/protein-levels-in-plasma-highly-predictive-of-future-dementia-risk-according-to-uk-biobank-study/2457313/People with higher baseline plasma levels of certain proteins, including glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), growth/differentiation factor 15 (GDF15), and latent-transforming growth factor beta-binding protein 2 (LTBP2), had an elevated risk of d
- Favorable Outcomes Reported for Novel Therapy Frexalimab in Reducing Disease Activity in Those with Relapsing Multiple Sclerosishttps://reachmd.com/news/favorable-outcomes-reported-for-novel-therapy-frexalimab-in-reducing-disease-activity-in-those-with-relapsing-multiple-sclerosis/2457314/Frexalimab (SAR441344; Sanofi, Bridgewater, NJ), an investigational anti-CD40L monoclonal antibody, was shown to reduce disease activity in individuals with relapsing multiple sclerosis (RMS) according to study results published in The New England Journal of Medicine. Inhib